'Haley and DeSantis have infinitely less to account and apologize for than Trump does'
Frank Bruni in The New York Times
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
'Young voters are ripe for President Biden's taking'
Victor Shi in USA Today
The "hungriest constituency" determines elections, says Victor Shi in USA Today. "Historic" Black turnout lifted Barack Obama to victory, twice. Enthusiastic women voters clinched Hillary Clinton's 2016 Democratic nomination. The group President Joe Biden needs is "young voters." Polls suggest he's losing them, but he isn't. He just needs to make them see his achievements on issues "from climate change to student loan forgiveness to gun violence," and show he can play "hardball" with Republicans.
'Donald Trump and his allies have come up short'
Norman Eisen, Richard W. Painter, and Joyce Vance in The Atlanta Journal-Constitution
The "sensational" allegation of impropriety against Fulton County, Georgia, District Attorney Fani Willis won't let Donald Trump off the hook, say Norman Eisen, Richard W. Painter, and Joyce Vance in The Atlanta Journal-Constitution. One of Trump's Georgia election-subversion co-defendants, GOP operative Michael Roman, claims Willis is romantically involved with the special prosecutor she hired, Nathan Wade. Even if the allegation were true, "a big if," it wouldn't justify Trump's call for dismissal "under Georgia law."
'No one has a God-given right to have someone create "free" new treatments for their disease'
Christopher Jacobs in The Federalist
Pharmaceutical companies responded quickly to Medicare drug price controls Democrats "rammed through," says Christopher Jacobs in The Federalists. The rules give companies limited years to market new medicines before price "negotiation" starts. "Companies whose drugs could treat multiple medical conditions, such as different types of cancer," have started slow-walking some trials to get approval "for the broadest possible condition first," to maximize profits. Patients who need new drugs for rare diseases are the "ultimate losers."
-
Why Britain is struggling to stop the ransomware cyberattacksThe Explainer New business models have greatly lowered barriers to entry for criminal hackers
-
Greene’s rebellion: a Maga hardliner turns against TrumpIn the Spotlight The Georgia congresswoman’s independent streak has ‘not gone unnoticed’ by the president
-
Crossword: October 26, 2025The Week's daily crossword puzzle
-
Marjorie Taylor Greene’s rebellion: Maga hardliner turns on Trump
In the Spotlight The Georgia congresswoman’s independent streak has ‘not gone unnoticed’ by the president
-
‘Congratulations on your house, but maybe try a greyhound instead’Instant Opinion Opinion, comment and editorials of the day
-
Five takeaways from Plaid Cymru’s historic Caerphilly by-election winThe Explainer The ‘big beasts’ were ‘humbled’ but there was disappointment for second-placed Reform too
-
Trump wants to exert control over federal architectureThe Explainer Beyond his ballroom, Trump has several other architectural plans in mind
-
‘The nonviolence resulted from the organizers’ message’Instant Opinion Opinion, comment and editorials of the day
-
Trump’s huge ballroom to replace razed East WingSpeed Read The White House’s east wing is being torn down amid ballroom construction
-
Trump expands boat strikes to Pacific, killing 5 moreSpeed Read The US military destroyed two more alleged drug smuggling boats in international waters
-
Whistles emerge as Chicago’s tool to fight ICEIN THE SPOTLIGHT As federal agents continue raiding the city, communities have turned to noisemakers to create a warning system
